Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin...

por Ham, Janneke C., van Meerten, Esther, Fiets, W. Edward, Beerepoot, Laurens V., Jeurissen, Frank J. F., Slingerland, Marije, Jonker, Marianne A., Husson, Olga, van der Graaf, Winette T. A., van Herpen, Carla M. L.
Publicado 2020

Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy...

por Driessen, Chantal M., Ham, Janneke C., te Loo, Maroeska, van Meerten, Esther, van Lamoen, Maurits, Hakobjan, Marina H., Takes, Robert P., van der Graaf, Winette T., Kaanders, Johannes H., Coenen, Marieke J.H., van Herpen, Carla M.
Publicado 2019